Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has submitted the Annual Report of the Company for the financial year 2021-22 (‘Annual Report’) along with the Notice convening 17th Annual General Meeting (notice) of the Company, scheduled to be held on Thursday, September 22, 2022 at 05:00 pm IST through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM), copies of which are being e-mailed to the shareholders of the Company whose e-mail ids are registered with the Company’s RTA, Link Intime India or their respective Depository Participant. The Annual Report along with the Notice is also available on the website of the Company and can be accessed at https://sparc.life/sites/default/files/2021-22/Annual-Report-forthe-FY-22-including-Notice-of-17th-AGM.pdf. The remote e-voting period shall commence on Monday, September 19, 2022 at 09:00 am (IST) and shall end on Wednesday, September 21, 2022 at 05:00 pm (IST).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 435.70 |
| Indegene | 486.80 |
| CMS Info Systems | 318.00 |
| JITF Infralogistics | 338.00 |
| Sagility | 42.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: